However, BPC-157 is not approved for human use by any regulatory agency, and its safety remains largely unproven
It is not approved for human or veterinary diagnostic, therapeutic, or recreational use
[1] [4] Published phase 2 trial data (Jastreboff et al., NEJM , 2023) reported dose ranges from 1 mg up to 12 mg weekly, with higher doses associated with greater weight loss but also increased rates of gastrointestinal side effects
Wed love to meet you, contact us today to schedule an appointment and take the first step towards a more comfortable and healthier life!
Occupational hazards like stress, sleep disruption, and shift work play a key role
Acute AOD9604 exposure, however, still increased energy expenditure and fat oxidation in the knockout animals